SMRUTHI ORGANICS
|
SMRUTHI ORGANICS Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 3.14 | 3.61 | 9.07 | 14.95 | 22.14 |
| CEPS(Rs) | 8.08 | 7.60 | 12.79 | 18.39 | 11.21 |
| DPS(Rs) | 1.50 | 2.00 | 3.00 | 3.00 | 3.00 |
| Book NAV/Share(Rs) | 60.82 | 59.55 | 58.68 | 52.85 | 111.29 |
| Tax Rate(%) | 27.76 | 8.07 | 24.62 | 28.88 | 30.14 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 9.04 | 6.90 | 13.80 | 22.56 | 11.62 |
| EBIT Margin(%) | 4.82 | 3.75 | 11.05 | 19.88 | 11.65 |
| Pre Tax Margin(%) | 3.76 | 3.17 | 10.31 | 19.02 | 9.22 |
| PAT Margin (%) | 2.71 | 2.91 | 7.78 | 13.52 | 6.44 |
| Cash Profit Margin (%) | 6.99 | 6.14 | 10.96 | 16.64 | 9.79 |
| Performance Ratios | |||||
| ROA(%) | 3.18 | 4.24 | 11.57 | 19.05 | 8.96 |
| ROE(%) | 5.21 | 6.11 | 16.27 | 33.23 | 21.43 |
| ROCE(%) | 8.22 | 7.39 | 21.00 | 39.08 | 25.00 |
| Asset Turnover(x) | 1.17 | 1.46 | 1.49 | 1.41 | 1.39 |
| Sales/Fixed Asset(x) | 1.05 | 1.20 | 1.21 | 1.20 | 1.30 |
| Working Capital/Sales(x) | 3.97 | 4.75 | 3.62 | 3.84 | 8.66 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.95 | 0.83 | 0.83 | 0.84 | 0.77 |
| Receivable days | 107.56 | 84.30 | 68.12 | 66.25 | 84.89 |
| Inventory Days | 74.16 | 56.56 | 52.02 | 50.80 | 55.39 |
| Payable days | 134.43 | 71.26 | 57.14 | 99.35 | 113.82 |
| Valuation Parameters | |||||
| PER(x) | 46.58 | 35.61 | 24.69 | 14.87 | 1.08 |
| PCE(x) | 18.09 | 16.90 | 17.51 | 12.09 | 2.14 |
| Price/Book(x) | 2.40 | 2.16 | 3.82 | 4.21 | 0.65 |
| Yield(%) | 1.03 | 1.56 | 1.34 | 1.35 | 4.17 |
| EV/Net Sales(x) | 1.40 | 1.07 | 1.94 | 1.96 | 0.30 |
| EV/Core EBITDA(x) | 14.82 | 15.27 | 13.60 | 8.54 | 2.01 |
| EV/EBIT(x) | 27.96 | 28.41 | 17.53 | 9.88 | 2.59 |
| EV/CE(x) | 2.19 | 2.05 | 2.95 | 2.71 | 0.45 |
| M Cap / Sales | 1.31 | 1.04 | 1.92 | 2.01 | 0.21 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -9.50 | 5.75 | 5.43 | -3.49 | -4.61 |
| Core EBITDA Growth(%) | 21.67 | -47.99 | -34.65 | 48.00 | 12.51 |
| EBIT Growth(%) | 19.98 | -63.97 | -41.33 | 64.67 | 14.51 |
| PAT Growth(%) | -13.09 | -60.21 | -39.31 | 102.52 | 23.11 |
| EPS Growth(%) | -13.09 | -60.21 | -39.31 | -32.49 | 23.11 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.17 | 0.08 | 0.04 | 0.17 | 0.37 |
| Current Ratio(x) | 1.78 | 1.81 | 3.37 | 2.26 | 1.40 |
| Quick Ratio(x) | 1.08 | 1.16 | 2.09 | 1.57 | 0.95 |
| Interest Cover(x) | 4.53 | 6.46 | 15.00 | 23.00 | 4.80 |
| Total Debt/Mcap(x) | 0.07 | 0.04 | 0.01 | 0.04 | 0.57 |
Compare Financial Ratios of peers of SMRUTHI ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMRUTHI ORGANICS | ₹125.7 Cr | -2.3% | 2.9% | -23.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -2.8% | 7.6% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹153,258.0 Cr | -2.3% | 0.8% | 72.7% | Stock Analytics | |
| CIPLA | ₹116,434.0 Cr | -5.4% | -1.5% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹109,474.0 Cr | -0.8% | 6.8% | 25.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,465.9 Cr | -5.5% | 1.6% | -5.1% | Stock Analytics | |
SMRUTHI ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMRUTHI ORGANICS | -2.3% |
2.9% |
-23.4% |
| SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses
